Radnostix Q3 net loss widens to $842,242; revenue falls 22% to $2.57 million
NNE•Radnostix reported a third-quarter 2026 net loss of $842,242 and revenue of $2.57 million, down 22%. It agreed to sell its Fluorine Products assets to Nano Nuclear Energy for $13.5 million, subject to NRC approval and other conditions.
1. Quarterly results
Radnostix’s third-quarter 2026 net loss widened to $842,242 as revenue fell 22% to $2.57 million, primarily due to delayed Cobalt contracts and lower Calibration & Reference Products revenue. Theranostics Products revenue rose 15% to $1.71 million, reflecting customer growth.
2. Asset sale
The company agreed to sell its Fluorine Products assets to Nano Nuclear Energy for $13.5 million, subject to NRC approval and other conditions.



